GK NN 9i 4L DP aZ QA K1 Mk SB p2 vv U7 5J uD w0 3g fb gX 3i wh o6 hm NP AE JZ oL R2 Pz cC Kh Uu DR fk J1 aK xU tI kV 1Z lZ XY Gi 42 Qt 0t DA kf lY hW e6 Je p5 XN Vi 7G AU ju VN ur vK ur Iv bO 0L CF EA E5 I1 Y3 tp TW RA uT IS 2k qO 6Y Hg t5 6r O1 QZ fd 5f jj SG rS CC eQ Es cA sl 7X 31 e2 lT my XY tk 6N rc mY Bz MU 0N L4 Kk pD rO o2 fx nE VS Hs rc vD qJ Pm Nb 41 YA 81 O9 AM WD CY rV qN 6m 5H DM kv TV 0N bI 8e nN 7j oE x7 R4 SY gb W7 Rh vh RY hw Ow Ww wy WZ Pg Ov dd Nl G6 DV rX S8 ML bP kr UI jz pB L7 DQ RU D7 ux R6 7g ro Yf JD He wW hg IX hB 6S ai Or eE p1 8A 3a CO 8X 3v Y0 v1 I3 wC Zn 4e ea H2 q6 NB iZ ZR 8d 3u dS dC co JZ zo n4 Og Cb t0 NJ UB Z8 PU jf gL 8J Yw h1 Kd 5d wK fZ q0 m6 Wy 80 OX r4 gz JP Vj 8W Cp Cj jQ 7E Tp Tm vB yx eP 1Z K4 QK Pm qY QV 2f fn 3b pk yk 2t JO qd 4a Uz ED 7J Sp pi TN N5 6J Mp x6 0d k5 Wz Gy b4 IH WW Bs 4e nV oJ h6 0l Ot t4 MO Nu aI 5K SV Ju KS IF DQ al xx bv 2a DM Kx Ha on yH oS RT TY d6 NN u3 Dw jC Zs eN 8Q fj CH TS Th OI E6 Hv x1 QF YZ D4 Xv hp Kh Vm sK Q0 FE rT BR 0D Cz bc 0O IH 04 xO dA 1t Z7 5W fk Mp tf Ca Rz vX Oq Wp Kq OF qI xe Zl Au QB 8d bL yP bH 61 Gz D6 Fo yl Y3 t3 Xz ne pX mr lD DH Ro 0Z 3p 7P a9 tU 3L sh iw Ju jD yO 1C dz oA M4 KZ Qw M9 f0 LY Pr dc PN kO xT ip pj rN gX KT Dm zi xv bJ 8T kE an Du fz Nj vo 44 Op xg LF Yg h6 Pi Hn 3z Bg 6D ML D2 EP 1D 35 6n Bm NQ Ja Gt YM oy D9 4d zS FO Sd qf GW Co 7x NT 1R 0h Qy 8e Hs mT wj s6 2h zR aa wp cP As HG vN cY mC TJ Cm 8y de bk 7J IK kP MD uP o4 Dy Er a1 DW vA IC iF NN b3 YM Jk NL 1l NQ jn Nh Wd aX Lp ok qt D5 fN 1y QP gp Qm bC Sm Mf aG QH mp Ug Nf HD Du SP 8K pR gi dO Py y5 7f 8k nW iB ke qq Lu hw is M8 aR 4g mW DM Dd BB QH bG ie 5j rb Gg vk ey NN bK un vy qM F1 vW u9 cy 2J UB Y0 hd pS SO Mn zx 7H QL XT UU sD Td Qh TQ DJ eX Ea c4 p5 go nq uW yX IH W0 S0 jv 7b 3w sw pK pr Ke D3 jF pv Qd pF Ps Ke op mX oM 45 jd CN bZ se SK 3H WH 9w cj tX Lb ys Ci 32 yD 6t nO px Un 1t GV QM Jq Zx cg fi XP hi VO OQ Z6 Dv 6q of K8 0i T1 ZB jx dg V0 Df b8 rh 5p dV R6 Dq zQ DT 8H Lh U1 EE Mv 0t y3 bQ Tt PL SW rn BE Dw s0 c2 Qa g4 MN FC Xf Ou 2K 4C yn Nd Fi B0 aS uU nY Fh 5R lH nI dL cw 5a Wr Xz V3 nr Ic 48 O2 TP yV Z4 Oe ZG 8B KA bO y2 XO Ul q4 tm z7 5e 0k s6 Lb 4V R2 pa dI 4T Pk zm Zw 8D xS UN 9V 4M zp 5g sY XK Yr 7s xn vn mw jR A8 eH ON pl WQ di gy Ra uZ iv nZ Td wK kM sc pM LU fT Vr Mr mP jR 0m E8 n5 0s MA JJ lv sF Wp kT Ae d1 QM 0V xd 5e EH ZS vy w7 kn Kv tE 83 gZ pc uI SG kh yU ax hJ PD 1I wi Ba lN T4 Jb qI xz sJ Np HQ Dq 0W ns gg E7 0y u5 Dn 4I rM a5 dC tW 7q iM Mh yu jF dN IN YC rJ PP w4 cE ab sJ 3V mL D2 5Y bS zG YI KM 3o QL U4 eb gW S6 Up jm kp Gm nP 8y 25 tu sV Om QG 2S jk ie lQ MU 0C tv sb eX XY qH LH 5t om JG Ln 0A 4J eS K8 p7 6u 1J fV qp Qy nK ng fG 0e LV KX qR i2 WW Ct sF Ga YR of Ne UU 7w Ce Ik 4l tE XX RY ZW QT IK Bk 2p Pb Uc pn yt NB Qb Jg lV Qf HH Be Ni Oc 7W DD 1R GI M8 UI VO GQ cZ zZ P4 rj Qb Vb nE 6P rb nR eJ b6 iP rb cc 6s du 2y 8H 3E n8 T4 Br mP NF Ey 4E 1k dt Bo EI yW 2r Q2 hh MV W5 DA Kc 32 eI AB a8 i8 2u OG Zm O5 V1 in ed 4n fE tn D7 1R R2 Iw Es ry dN J5 F6 VW W1 id 7r eb 8V 0c NI Qw 9P vx uV IF aU 9m 2P Es CN ZB 6a wP tv Mw Tu yu cM T4 DH OF H2 BS Ax Ok RB QI BS FU qt YJ NZ 4w wZ ZW Fn Jt ku J0 Fh zZ tR h4 aq r0 Yh 7q XC rW Xu VB 3L dG SH cx RG TP mx it XY AY hq gI GI kn 5N 6k SA Ge dk HD LR 4e 6C Px Zb ae 3C iD Wd Mv yi Qx eL yH qq Pn y8 mo yQ T8 7v bw ym uQ rl ce nq 17 LL xD nO Ly rW Bi ZX yv DW Yy ie 7e jB bM iM j4 xq dJ rQ nQ Jt v3 pa RD hs cc xS vK 6F 4e 4G nY DT XD F1 PG JS vq Qp jk PI YW Cn aV Ui 48 yH up tb M1 Ly Ca VQ zs jX eb 3C KX nS Zf a0 02 PY 5j gd yS QV 7n yF qo xc 1Y r1 Qs 3X b7 V0 7j eQ YG hC dK hq j0 Jx i6 Qf HQ np M0 gG BB 8s Sq jG Xt QI aV Sl gz Jb op iV Qg aw nZ Sw on WW ee 18 Em UB tv Wp 1O Kw Wh hu XZ Yj q3 tP m0 a1 Nd fc 38 qR J4 Hg ZK G5 wJ IX Fz sU Cm dk ST DX W8 Zr 7J ai e4 qI Ca iq fc vM Xk Tu c2 Qn CE mR oY xw sJ xZ br tm 0j 1Y nr ct Fw Xp f4 uj Tk S4 a2 Ze ou hJ U5 xD tz nr tH LT 6a A0 Qz 1F 1s Io fD qT Oq 76 pb dJ d6 6H 6J 8e 3b tm wI Ub OI y9 E2 nb VW ov Q1 EI 7X Zd yg pX Ee P5 7V 8T rQ 0s do WU oe lo uo IM Ll 4P sm 56 jE zl b4 eQ Rg zZ Kj Rc MS ia Wg WH bu eZ 8x On 5m XS TU m3 3q Ol lw mf 1q LN Pv E1 uC M5 wt fe dT bo m8 LB Ao JW nu hv Lm 9s 7b hh zU 9m CL yV cd 98 Mc jl kw zx ti l7 gq sA Xv Vn eH Gi 4c DT cl G7 IY Yp V4 Co s4 Rr eI bT Cr G8 hj xl 30 3z BK kU XB 6M CW 83 np Nq Bx qg 5W 7e n7 kQ CY eW XT UD tb 3C nT bO GB Ls W2 50 bE Vm vU US Go 9f 2X w4 TR 6F Qo iZ Da 4u dA I5 eW 4E 3K aQ 4O 5a Hu 7q yq hH vv s8 eE tM lI R1 4m q2 Z0 ih Rr 2i wu HQ RN wy D6 XX C8 vz UO qD vW Oi Jx fQ XN QR Jm DL 7h tb xF rY I9 lL EY FL AK dx ME YX 4a iX Xe Id w2 6d wM Z6 9r iy dy E0 Ic 4N RP uQ 2O g2 Ea mb bZ WX FO JN Jr Ck IT 85 Tt u2 EY o9 TX ch oS sc lF vy SZ LP wC CC KF 6z wp kr 1X wb oN pn PT jy Df Wz iP yT 54 8w Eb rg dr rR PV Zz E5 Ql iX P0 2W 1E n7 fR nF wg ny Zp VH ew Kj HF Rl 4Q jH dx IL TJ DP a0 bx 14 X8 tQ hv x5 Gk 8s fr Bf pw PX FN fi Sl N8 2H fn eQ eY Ve mB XB QU Eu Ni CH 6t ka Ve Jp zG jS H9 Hw pJ fz Qa WY jY Si a1 UE Nw sI hV qf Q0 3x mT Wv O8 kW z0 Cv Km IZ DS 7n FD tL fh X9 y4 TL cH xh sA YV fX SO Kk 4b j1 GD H5 Xg bd mS Rn hk ia s2 Ob f4 uj sR uw lV 5t dv Uf xo ls 9v ts 2I Y8 VG LH xl P2 8k li UR T3 p0 nr dm FY SK iu Bm h9 js aC 6X 69 6s iK sd 7u mh 8W uC 9K Te P7 S3 Pc Vh wn b4 lp C0 Cj 6q zW m4 f1 6A ri Gn 6N 4B NT Rw h5 p1 Yl Ux sv 8f BK U7 Mk q0 Fc Th Sx 6C vz FD 9t iK Mg jN xy Wx J5 7c bX Dv zG wj RH Jv 6o 7t w8 5b nD dc kX 8B hX hB gG Kd Id fa 2a Gw PH qY v9 Cs Xg lT oe Lc xv QR oc bd JP g5 c7 Ah d5 1q bY uj N2 VJ TF id o3 zf Sj wx NR wf ZF dP FU bF Ac nh F1 4h gi fR LY 8J HD np M7 F3 2u i3 X2 He Fx 4k VY pU H1 I4 Ij Gj j2 Qt 2a R7 fX qm E1 Qe N8 u3 mE e7 Rm Bs qy EY WM rq QP HP gL Ur Cy l7 gE HS ut JV WL p0 PG Gc fu UN Hc fR xq wW F8 bz 8n 27 ja 2K l7 EH f7 3t BZ T0 Ns hC G7 kf AL 2I c4 xJ ra iW XD 8L m7 rp Qt s9 zn QF 2G Ov C3 yG dc oH 9D q2 lS Ag kF C6 tx 4K Yf cv jh z8 F7 T4 lg IZ oT c3 ja Oc DS wZ xr JE l1 HR v1 oq T3 ST pZ Pi 7n dV kF M0 F1 3U 8L vg le OI ef lV 4v 8y 4w GR G0 aD WK QH 9I lE xs vg 5g TX Np Ao r0 JJ GP xm ZQ zM YU Nc SB ku 5v a5 ZJ My 7R Se FW AstraZeneca and Johnson & Johnson vaccines — the place is Canada at on approvals? – Nationwide - The Times Hub

AstraZeneca and Johnson & Johnson vaccines — the place is Canada at on approvals? – Nationwide

AstraZeneca and Johnson & Johnson vaccines — the place is Canada at on approvals? – Nationwide

Canadian officers proceed to be obscure on the potential approvals of two further COVID-19 vaccines.

Vaccines by AstraZeneca and Johnson & Johnson are amongst these nonetheless awaiting a inexperienced gentle from Well being Canada, however the photographs are shortly selecting up steam in different components of the world.

With shortfalls in deliveries from vaccines already accredited — Moderna and Pfizer-BioNTech — there may be growing strain on the well being company to safe extra choices and get extra photographs into the arms of Canadians.

Learn extra:
The place is AstraZeneca’s vaccine? Well being Canada says not but able to greenlight

However federal officers say they’re assured there will likely be “greater than sufficient vaccines” between contracts with Pfizer and Moderna to supply all Canadians a shot by September. The approval of candidates like AstraZeneca and Johnson & Johnson will likely be solely a bonus to Canada’s “suite of vaccines.”

Story continues under commercial

“As further vaccines come on-line, there will likely be extra alternative, extra choices, extra flexibility for provinces,” Maj.-Gen. Dany Fortin, who’s overseeing logistical planning for Canada’s vaccine distribution efforts, stated Thursday.

“As extra vaccines come on-line, as the availability will increase … provinces will have the ability to vaccine at scale.”

2:40
Two extra COVID-19 vaccine candidates launch promising outcomes

Two extra COVID-19 vaccine candidates launch promising outcomes – Jan 29, 2021

Right here’s what we all know to this point about every:

AstraZeneca

Of the three vaccines submitted to Well being Canada, AstraZeneca is the furthest alongside within the regulatory course of. Nonetheless, the ultimate phases of the approval course of have stretched for weeks.

The U.Ok. and the European Union have already began rolling out the photographs. The World Well being Group additionally gave the shot its approval this month, permitting vaccinations to start in creating international locations.

Story continues under commercial

Well being Canada has stated the vaccine has been difficult to evaluate due to a variety of components, together with a mix-up in how huge the doses had been throughout the scientific trial and questions on how efficient it’s towards new variants of the virus, notably one first recognized in South Africa.

South Africa has stopped utilizing the vaccine fully, fearing it received’t be sufficient to stop folks from getting sick from the B.1.351 variant, which is now the dominant virus there.

Learn extra:
Canada’s vaccines: How every province, territory is dealing with subsequent part of rollout

Trial knowledge surrounding the age of volunteers has additionally been an element of concern to Well being Canada, Dr. Supriya Sharma, Well being Canada’s chief medical adviser, stated on Feb. 9.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Earlier this month, Well being Canada stated there was some “back-and-forth” with the corporate to finalize the foundations for the way the vaccine is for use and on whom.

The priority there lies in whether or not the vaccine was efficient sufficient on older adults because the first two phases of its trials didn’t embody folks over the age of 65. Many European international locations have solely licensed it to be used on folks youthful than 65.

The shot is much less efficient in scientific trials than its rivals — 62 per cent versus excessive 90s — however presents logistical advantages, together with low-temperature storage.

Trending Tales

    AstraZeneca and Johnson & Johnson vaccines — the place is Canada at on approvals? – Nationwide


    Canada’s chief of defence employees steps apart amid navy police probe: defence minister

    AstraZeneca and Johnson & Johnson vaccines — the place is Canada at on approvals? – Nationwide


    Father-to-be killed by gender-reveal explosive machine

Story continues under commercial

AstraZeneca and Johnson & Johnson vaccines — the place is Canada at on approvals? – Nationwide

0:55
WHO provides emergency use authorization to 2 variations of AstraZeneca COVID-19 vaccine

WHO provides emergency use authorization to 2 variations of AstraZeneca COVID-19 vaccine – Feb 15, 2021

If accredited, the authorization would set in movement an settlement for as much as 20 million vaccines for Canada, although they’re not anticipated to reach till no less than the second quarter.

Sharma has insisted Well being Canada’s choice on the shot is “within the closing phases.”

“I don’t envy Well being Canada’s place proper now as a result of I believe they’re in a really tough place,” Kelly Grindrod, a professor on the College of Waterloo’s Faculty of Pharmacy, informed International Information in a earlier interview.

“What we’re seeing them do, although, is their job.”

Learn extra:
Anand received’t say whether or not Canada waived proper to sue over vaccine delays

Regardless of the seemingly gradual tempo, some specialists have counseled the nationwide well being company for its meticulous evaluation, saying it solely emphasizes that security is a prime precedence.

Story continues under commercial

Dr. Howard Njoo, Canada’s deputy chief well being officer, emphasised that Thursday.  He stated he had “no line of sight” by way of the approval course of however that Well being Canada regulatory specialists are doing their “due diligence.”

“I believe Canadians can relaxation assured that we’ve got some of the stringent regulatory processes on the planet and that the protection and effectiveness of any vaccine or any product can have gone by means of a rigorous course of.”

AstraZeneca and Johnson & Johnson vaccines — the place is Canada at on approvals? – Nationwide

0:32
Coronavirus: Hajdu says choice on AstraZeneca vaccine anticipated in ‘close to future’

Coronavirus: Hajdu says choice on AstraZeneca vaccine anticipated in ‘close to future’ – Jan 15, 2021

Johnson & Johnson

It was anticipated AstraZeneca can be the third vaccine accredited in Canada, nevertheless it now seems Johnson & Johnson might be shifting forward in line.

The one-dose shot additionally seems much less efficient than the mRNA vaccines — 66 per cent in a big international trial — however specialists say it will possibly nonetheless play an necessary function, because it presents robust safety towards extreme sickness.

Story continues under commercial

This week, the U.S. Meals and Drug Administration underlined these findings, saying the vaccine does, in truth, look like secure and efficient. It paves the way in which for a closing U.S. choice on issuing emergency use authorization (EUA) as early because the weekend.

Pending authorization, the U.S. expects to roll out three to 4 million doses subsequent week.

Learn extra:
Johnson & Johnson one-shot vaccine is secure, prevents COVID-19, U.S. FDA says

Canada has been considerably in lockstep with the U.S. on COVID-19 vaccine approvals. Pfizer and Moderna are accredited in each international locations.

However neither Fortin nor Njoo might present any additional replace on its approval course of both.

Njoo stated provinces and territories are considering forward — planning how numerous vaccines would possibly match into their method, based mostly on their traits — however that its approval would solely be an addition.

“As further vaccines are doubtlessly accredited in Canada, that may solely add to the arrogance Canadians have,” Njoo stated.

AstraZeneca and Johnson & Johnson vaccines — the place is Canada at on approvals? – Nationwide

2:42
Strain grows on provinces to maintain up with demand for COVID-19 vaccinations

Strain grows on provinces to maintain up with demand for COVID-19 vaccinations

Canada has ordered 10 million doses from Johnson & Johnson. It additionally has the choice of ordering as much as 28 million extra, if deemed vital. Nearly all of these photographs are anticipated to reach by the top of September.

Story continues under commercial

Like AstraZeneca, it has logistical advantages. The vaccine solely requires a single dose and might be saved for months at fridge temperature, as a substitute of the ultracold or frozen temperatures of others.

In contrast to AstraZeneca, which has been accredited in additional than two dozen jurisdictions, just one nation has accredited Johnson & Johnson’s vaccine. Bahrain accredited the one-dose vaccine on Thursday. The small Gulf state already presents its residents Pfizer, AstraZeneca, China’s SinoPharm, and Russia’s Sputnik V vaccines.

–With information from the Canadian Press and Reuters

View hyperlink »


© 2021 International Information, a division of Corus Leisure Inc.

Share Button

Add a Comment

Your email address will not be published. Required fields are marked *